Paper11368293
Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients.
Wallemacq PE and 1 other. Clin Pharmacokinet, 2001. Cited by 124 papers, by iCite.
Cite this record
ConductScience Library. Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients. Papers, record 11368293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11368293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunosuppressive Agents | Major topic |
| Tacrolimus | Major topic |
| Adult | |
| Chemical Phenomena | |
| Chemistry, Physical | |
| Child | |
| Drug Interactions | |
| Humans |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04645667 | Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT) | Background |
Source ClinicalTrials.gov
References90
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2445721 | FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. | J Antibiot (Tokyo) | 1987 | https://conductscience.org/library/papers/2445721 | PubMed |
| 2 | 2445722 | FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. | J Antibiot (Tokyo) | 1987 | https://conductscience.org/library/papers/2445722 | PubMed |
| 3 | 1703356 | FK 506 inhibition of cyclosporine metabolism by human liver microsomes. | Transplant Proc | 1991 | https://conductscience.org/library/papers/1703356 | PubMed |
| 4 | 1377995 | Radioreceptor assay for quantifying FK-506 immunosuppressant in whole blood. | Clin Chem | 1992 | https://conductscience.org/library/papers/1377995 | PubMed |
| 5 | 9287412 | Comparison of old and new IMX assays for monitoring of tacrolimus levels. | Transpl Int | 1997 | https://conductscience.org/library/papers/9287412 | PubMed |
| 6 | 7693372 | FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. | Clin Chem | 1993 | https://conductscience.org/library/papers/7693372 | PubMed |
| 7 | 7680714 | Plasma protein binding of tacrolimus in humans. | J Pharm Sci | 1993 | https://conductscience.org/library/papers/7680714 | PubMed |
| 8 | 7537398 | Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients. | Transplantation | 1995 | https://conductscience.org/library/papers/7537398 | PubMed |
| 9 | 8585114 | Simplified high-performance liquid chromatography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay. | Ther Drug Monit | 1995 | https://conductscience.org/library/papers/8585114 | PubMed |
| 10 | 10410178 | Diltiazem increases tacrolimus concentrations. | Ann Pharmacother | 1999 | https://conductscience.org/library/papers/10410178 | PubMed |
| 11 | 7533356 | Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations. | Transplant Proc | 1995 | https://conductscience.org/library/papers/7533356 | PubMed |
| 12 | 9664950 | Dosing of MMF in combination with tacrolimus for steroid-resistant vascular rejection in pediatric renal allografts. | Transpl Int | 1998 | https://conductscience.org/library/papers/9664950 | PubMed |
| 13 | 1721260 | Monitoring FK 506 concentrations in plasma and whole blood. | Transplant Proc | 1991 | https://conductscience.org/library/papers/1721260 | PubMed |
| 14 | 7544705 | HPLC-microparticle enzyme immunoassay specific for tacrolimus in whole blood of hepatic and renal transplant patients. | Clin Chem | 1995 | https://conductscience.org/library/papers/7544705 | PubMed |
| 15 | 11294511 | Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid. | Ther Drug Monit | 2001 | https://conductscience.org/library/papers/11294511 | PubMed |
| 16 | 7685933 | Differences in oral FK506 dose requirements between adult and pediatric liver transplant patients. | Transplantation | 1993 | https://conductscience.org/library/papers/7685933 | PubMed |
| 17 | 9246018 | Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. | Clin Pharmacol Ther | 1997 | https://conductscience.org/library/papers/9246018 | PubMed |
| 18 | 2477714 | A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. | Nature | 1989 | https://conductscience.org/library/papers/2477714 | PubMed |
| 19 | 8721287 | Stability of FK506 in blood samples. | Ther Drug Monit | 1996 | https://conductscience.org/library/papers/8721287 | PubMed |
| 20 | 9269646 | Pharmacokinetics of tacrolimus (FK 506) in children and adolescents with renal transplants. | Nephrol Dial Transplant | 1997 | https://conductscience.org/library/papers/9269646 | PubMed |
Cited by61
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42814375 | Structured Evaluation of Model-Informed Precision Dosing of Mycophenolic Acid and Tacrolimus in Pediatric Patients with Kidney Disease. | Clin Pharmacokinet | 2026 | https://conductscience.org/library/papers/42814375 | PubMed |
| 42758417 | Concentration-to-Dose Ratio Differences Between Once-Daily Tacrolimus Formulations: A Five-Year Real-World Pharmacokinetic Study in Kidney Transplantation. | Eur J Drug Metab Pharmacokinet | 2026 | https://conductscience.org/library/papers/42758417 | PubMed |
| 42338958 | Comparative bioequivalence of 1 mg and 4 mg tacrolimus extended-release tablets: randomized, open label, fully replicate, crossover trials in healthy adult subjects. | Front Nephrol | 2026 | https://conductscience.org/library/papers/42338958 | PubMed |
| 41531243 | Mechanism-informed machine learning for individualized tacrolimus dose adjustment in the early post-kidney transplant period. | Br J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/41531243 | PubMed |
| 41012521 | Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41012521 | PubMed |
| 40908372 | Concentration-dependent blood binding: assessing implications through physiologically based Pharmacokinetic modeling of tacrolimus as a case example. | J Pharmacokinet Pharmacodyn | 2025 | https://conductscience.org/library/papers/40908372 | PubMed |
| 40528069 | Tacrolimus Trough Concentrations are Not Impacted by Epstein-Barr Virus Serology and Viral Load in Pediatric Liver Transplant Recipients. | Eur J Drug Metab Pharmacokinet | 2025 | https://conductscience.org/library/papers/40528069 | PubMed |
| 39844338 | Drug-drug interaction between ensitrelvir and tacrolimus in a patient undergoing treatment for COVID-19: a case report. | J Pharm Health Care Sci | 2025 | https://conductscience.org/library/papers/39844338 | PubMed |
| 39836342 | Tacrolimus and diabetic rodent models. | Pharmacol Rep | 2025 | https://conductscience.org/library/papers/39836342 | PubMed |
| 39364052 | Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39364052 | PubMed |
| 38994750 | Steroid-tacrolimus drug-drug interaction and the effect of CYP3A genotypes. | Br J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/38994750 | PubMed |
| 38993881 | Tacrolimus-why pharmacokinetics matter in the clinic. | Front Transplant | 2023 | https://conductscience.org/library/papers/38993881 | PubMed |
| 38947962 | Tacrolimus-induced posterior reversible encephalopathy syndrome following liver transplantation. | World J Transplant | 2024 | https://conductscience.org/library/papers/38947962 | PubMed |
| 38674430 | Association of CYP3A4-392A/G, CYP3A5-6986A/G, and ABCB1-3435C/T Polymorphisms with Tacrolimus Dose, Serum Concentration, and Biochemical Parameters in Mexican Patients with Kidney Transplant. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/38674430 | PubMed |
| 38286164 | Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery. | Adv Drug Deliv Rev | 2024 | https://conductscience.org/library/papers/38286164 | PubMed |
| 37765200 | Investigating Tacrolimus Disposition in Paediatric Patients with a Physiologically Based Pharmacokinetic Model Incorporating CYP3A4 Ontogeny, Mechanistic Absorption and Red Blood Cell Binding. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37765200 | PubMed |
| 36119045 | The efficacy and safety of tacrolimus on top of glucocorticoids in the management of IIM-ILD: A retrospective and prospective study. | Front Immunol | 2022 | https://conductscience.org/library/papers/36119045 | PubMed |
| 35228813 | Prediction of Tacrolimus Dose/Weight-Adjusted Trough Concentration in Pediatric Refractory Nephrotic Syndrome: A Machine Learning Approach. | Pharmgenomics Pers Med | 2022 | https://conductscience.org/library/papers/35228813 | PubMed |
| 34817826 | Predictive Performance of Published Tacrolimus Population Pharmacokinetic Models in Thai Kidney Transplant Patients. | Eur J Drug Metab Pharmacokinet | 2022 | https://conductscience.org/library/papers/34817826 | PubMed |
| 34803692 | Monitoring Tacrolimus Concentrations in Whole Blood and Peripheral Blood Mononuclear Cells: Inter- and Intra-Patient Variability in a Cohort of Pediatric Patients. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34803692 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11368293
GET https://conductscience.org/api/papers/v1/11368293/references?page=2